Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Change in treatment strategies for adult acute lymphoblastic leukemia (ALL) according to prognostic factors and minimal residual disease.

Bone marrow transplantation - 1 Jul 1990

Hoelzer D

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Child, Preschool
Share to Infant
Share to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Philadelphia Chromosome

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Share to Prognosis

Share to Time Factors

Source

Identifiers

PMID: 2390642

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Change in treatment strategies for adult acute lymphoblastic leukemia (ALL) according to prognostic factors and minimal residual disease.PMID 2390642Read ↗

Biology and treatment of acute lymphoblastic leukemia.Semantic proximity Read ↗

The biology and therapy of adult acute lymphoblastic leukemia.Semantic proximity Read ↗

Children’s Oncology Group Blueprint for Research: Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Clinical updates in adult acute lymphoblastic leukemiaSemantic proximity Read ↗

Clinical Significance of Novel Subtypes of Acute Lymphoblastic Leukemia in the Context of Minimal Residual Disease–Directed TherapySemantic proximity Read ↗

Acute Lymphoblastic Leukemia: Monitoring Minimal Residual Disease as a Therapeutic PrincipleSemantic proximity Read ↗

Recent advances in the management of pediatric acute lymphoblastic leukemiaSemantic proximity Read ↗

Should minimal residual disease monitoring be the standard of care for all patients with acute promyelocytic leukemia?Semantic proximity Read ↗

[Childhood acute lymphoblastic leukemia (ALL)].Semantic proximity Read ↗

Reduced intensity of early intensification does not increase the risk of relapse in children with standard risk acute lymphoblastic leukemia - A multi-centric clinical study of GD-2008-ALL protocolSemantic proximity Read ↗

Management of adult Ph-positive acute lymphoblastic leukemia.Semantic proximity Read ↗

Development of Minimal Residual Disease–Directed Therapy in Acute Myeloid LeukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.